Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew T Wheeler

Showing results (91-100 of 190) with videos related to

Pageof 19
Sort By:
Circulation. Genomic and Precision Medicine|December 14, 2022
Efficacy and Safety of ARRY-371797 in <i>LMNA</i>-Related Dilated Cardiomyopathy: A Phase 2 StudyCalum A MacRae, Matthew R G Taylor, Luisa Mestroni, et al.
Journal of Clinical Medicine|June 26, 2025
Cardiopulmonary Recovery After Maximal Exercise in Individuals with Neuromuscular Disease and Limited MobilityYair Blumberg, Constance de Monts, Samuel Montalvo, et al.
Circulation|October 18, 2023
Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer CarvedilolKinya Seo, Yuta Yamamoto, Anna Kirillova, et al.
JAMA Cardiology|January 18, 2023
Effects of Mavacamten on Measures of Cardiopulmonary Exercise Testing Beyond Peak Oxygen Consumption: A Secondary Analysis of the EXPLORER-HCM Randomized TrialMatthew T Wheeler, Iacopo Olivotto, Perry M Elliott, et al.
Journal of Clinical Medicine|December 23, 2023
Assessing the Assisted Six-Minute Cycling Test as a Measure of Endurance in Non-Ambulatory Patients with Spinal Muscular Atrophy (SMA)Whitney J Tang, Bo Gu, Samuel Montalvo, et al.
Journal of the American College of Cardiology|June 6, 2015
Systematic Comparison of Digital Electrocardiograms From Healthy Athletes and Patients With Hypertrophic CardiomyopathyRachel E Bent, Matthew T Wheeler, David Hadley, et al.
Nature Metabolism|August 31, 2023
A defect in mitochondrial fatty acid synthesis impairs iron metabolism and causes elevated ceramide levelsDebdeep Dutta, Oguz Kanca, Seul Kee Byeon, et al.
JACC. Heart Failure|January 4, 2024
Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From the MAVA-LTE Study, EXPLORER-LTE CohortFlorian Rader, Artur Oręziak, Lubna Choudhury, et al.
The Lancet. Digital Health|December 16, 2020
The effect of digital physical activity interventions on daily step count: a randomised controlled crossover substudy of the MyHeart Counts Cardiovascular Health StudyAnna Shcherbina, Steven G Hershman, Laura Lazzeroni, et al.
Circulation. Genomic and Precision Medicine|November 22, 2021
Mono- and Biallelic Protein-Truncating Variants in Alpha-Actinin 2 Cause Cardiomyopathy Through Distinct MechanismsMalene E Lindholm, David Jimenez-Morales, Han Zhu, et al.
Pageof 19

Showing results (91-100 of 190) with videos related to

Sort By:
Pageof 19
Circulation. Genomic and Precision Medicine|December 14, 2022
Efficacy and Safety of ARRY-371797 in <i>LMNA</i>-Related Dilated Cardiomyopathy: A Phase 2 StudyCalum A MacRae, Matthew R G Taylor, Luisa Mestroni, et al.
Journal of Clinical Medicine|June 26, 2025
Cardiopulmonary Recovery After Maximal Exercise in Individuals with Neuromuscular Disease and Limited MobilityYair Blumberg, Constance de Monts, Samuel Montalvo, et al.
Circulation|October 18, 2023
Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer CarvedilolKinya Seo, Yuta Yamamoto, Anna Kirillova, et al.
JAMA Cardiology|January 18, 2023
Effects of Mavacamten on Measures of Cardiopulmonary Exercise Testing Beyond Peak Oxygen Consumption: A Secondary Analysis of the EXPLORER-HCM Randomized TrialMatthew T Wheeler, Iacopo Olivotto, Perry M Elliott, et al.
Journal of Clinical Medicine|December 23, 2023
Assessing the Assisted Six-Minute Cycling Test as a Measure of Endurance in Non-Ambulatory Patients with Spinal Muscular Atrophy (SMA)Whitney J Tang, Bo Gu, Samuel Montalvo, et al.
Journal of the American College of Cardiology|June 6, 2015
Systematic Comparison of Digital Electrocardiograms From Healthy Athletes and Patients With Hypertrophic CardiomyopathyRachel E Bent, Matthew T Wheeler, David Hadley, et al.
Nature Metabolism|August 31, 2023
A defect in mitochondrial fatty acid synthesis impairs iron metabolism and causes elevated ceramide levelsDebdeep Dutta, Oguz Kanca, Seul Kee Byeon, et al.
JACC. Heart Failure|January 4, 2024
Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From the MAVA-LTE Study, EXPLORER-LTE CohortFlorian Rader, Artur Oręziak, Lubna Choudhury, et al.
The Lancet. Digital Health|December 16, 2020
The effect of digital physical activity interventions on daily step count: a randomised controlled crossover substudy of the MyHeart Counts Cardiovascular Health StudyAnna Shcherbina, Steven G Hershman, Laura Lazzeroni, et al.
Circulation. Genomic and Precision Medicine|November 22, 2021
Mono- and Biallelic Protein-Truncating Variants in Alpha-Actinin 2 Cause Cardiomyopathy Through Distinct MechanismsMalene E Lindholm, David Jimenez-Morales, Han Zhu, et al.
Pageof 19